BLX‐1002 restores glucose sensitivity and enhances insulin secretion stimulated by GLP‐1 and sulfonylurea in type 2 diabetic pancreatic islets
BLX‐1002 is a novel thiazolidinedione with no peroxisome proliferator‐activated receptor (PPAR) activity that has been shown to improve glycemia in type 2 diabetes without weight gain. We previously found that BLX‐1002 selectively augments glucose‐sensitive (but not basal) insulin secretion in norma...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Wiley Periodicals, Inc.
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098742/ |